insights_auto
Why is GENB up 3.90%?
Dive Deeperchevron_right
GENB:NASDAQ
Generate Biomedicines Inc
$13.06
arrow_upward
+3.90%(+0.49) 1D
Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GENB...
Open
$12.90
High
$13.17
Low
$12.47
Mkt. cap
1.68B
Avg. vol.
1.04M
Volume
632.20K
52-wk high
$22.67
52-wk low
$11.00
No. of employees
312
Open
$12.90
High
$13.17
Low
$12.47
Mkt. cap
1.68B
Avg. vol.
1.04M
Volume
632.20K
52-wk high
$22.67
52-wk low
$11.00
No. of employees
312
News stories
From web sources and news partners
Nacionale
·
4 hours ago
Was Thursday's stock market drop the biggest ever? In points, yes. In percent, not even close
Reuters Connect
·
4 hours ago
A screen displays the Dow Jones Industrial Average after the closing bell on the floor of the NYSE in New York
marketscreener.com
·
4 hours ago
S&P 500 Posts Weekly Drop as Energy, Technology Slide in Election Aftermath
www.tokenpost.com
·
3 hours ago
Tech’s 37% S&P 500 Weight Raises Risk From AI Stock Rotation
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersSomerville, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitegeneratebiomedicines.com